Sarepta Therapeutics Earnings
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 3:16 PM ET
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$0.17
Sarepta Therapeutics earnings summary
Sarepta Therapeutics is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $0.17. In its most recent report on Aug 5, 2026 (Q2 2026), SRPT posted EPS of $-0.05. Revenue for the quarter was $401.3 million.
Quarterly EPS is down 102.6% from the same quarter a year earlier. Across the last 16 reports, SRPT shares moved an average of 5.8% (in either direction) in the first trading session after results, rising 7 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
SRPT earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $-0.05 | — | +7.9% |
| May 6, 2026 | — | $2.88 | — | -12.1% |
| Jan 12, 2026 | — | $-3.93 | — | 0.0% |
| Nov 3, 2025 | — | $-0.50 | — | +6.7% |
| Jul 16, 2025 | — | $1.89 | — | -15.3% |
| May 6, 2025 | — | $-4.60 | — | +0.4% |
| Jan 13, 2025 | — | $1.50 | — | -1.3% |
| Nov 6, 2024 | — | $0.34 | — | -14.0% |
| Aug 7, 2024 | — | $0.07 | — | +6.5% |
| May 1, 2024 | — | $0.37 | — | -1.4% |
| Feb 28, 2024 | — | $0.79 | — | -3.3% |
| Nov 1, 2023 | — | $-0.46 | — | +1.8% |
| Aug 2, 2023 | — | $-0.27 | — | +2.6% |
| May 2, 2023 | — | $-5.86 | — | -8.2% |
| Feb 28, 2023 | — | $-1.24 | — | -7.5% |
| Nov 2, 2022 | — | $-2.94 | — | +3.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.